| [1] |
Walsh MC，Szefler S，Davis J，et al．Summary proceedings from the bronchopulmonary dysplasia group[J]．Pediatrics，2006，117(3) :352-356．
|
| [2] |
Crowley P．Prophylactic corticosteroids for preterm birth [J]．Cochrane Database Syst Rev，2000，(2)，CD000065．
|
| [3] |
Wapner RJ．Antenatal corticosteroids for periviable birth [J]．Semin Perinatol，2013，37(6) :410-413．
|
| [4] |
Massaro D，Massaro GD．Invited review：pulmonary alveoli：formation，the "call for oxygen，" and other regulators[J]．Am J Physiol Lung Cell Mol Physiol，2002，282(3):L345-L358．
|
| [5] |
Liu J，Feng ZC，Li J，Wang Q．Antenatal dexamethasone has no adverse effects on child physical and cognitive development: a long-term cohort follow-up investigation[J]．J Matern Fetal Neonatal Med，2012，25(11):2369-2371．
|
| [6] |
Wong D，Abdel-Latif M，Kent A．Antenatal steroid exposure and outcomes of very premature infants：a regional cohort study[J]．Arch Dis Child Fetal Neonatal Ed，2014．99(1)，F12-20．
|
| [7] |
Collins JJ，Kunzmann S，Kuypers E，et al．Antenatal glucocorticoids counteract LPS changes in TGF-beta pathway and caveolin-1 in ovine fetal lung[J]．Am J Physiol Lung Cell Mol Physiol，2013，304(6):L438-L444．
|
| [8] |
Halliday HL，Ehrenkranz RA，Doyle LW．Early postnatal (<96 hours)corticosteroids for preventing chronic lung disease in preterm infants [J]．Cochrane Database Syst Rev，2003，(1)，CD001146．
|
| [9] |
Halliday HL，Ehrenkranz RA，Doyle LW．Early (<8 days)postnatal corticosteroids for preventing chronic lung disease in preterm infants [J]．Cochrane Database Syst Rev，2010，(1):CD001146．
|
| [10] |
Kang JL，Park W，Pack IS，et al．Inhaled nitric oxide attenuates acute lung injury via inhibition of nuclear factor-kappa B and inflammation[J]．J Appl Physiol，2002，92(2):795-801．
|
| [11] |
Field D，Elbourne D，Truesdale A，et al．Neonatal ventilation with inhaled nitric oxide versus ventilatory support without inhaled nitric oxide for preterm infants with severe respiratory failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339)[J]．Pediatrics，2005，115(4):926-936．
|
| [12] |
Schmidt B，Roberts RS，Davis P，et al．Caffeine therapy for apnea of prematurity[J]．N Engl J Med，2006，354(20):2112-2121．
|
| [13] |
孔令凯，孔祥永，李丽华，等．双水平正压通气和经鼻持续气道正压通气在早产儿呼吸窘迫综合征IinSurE治疗方式应用的比较[J/CD]．中华妇幼临床医学杂志：电子版，2013，9(5):579-585．
|
| [14] |
Leone F，Trevisanuto D，Cavallin F，et al．Efficacy of InSurE during nasal CPAP in preterm infants with respiratory distress syndrome[J]．Minerva Pediatr，2013，65(2):187-192．
|
| [15] |
Jefferies AL．Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants[J]．Paediatr Child Health，2012，17(10):573-574．
|
| [16] |
Onland W，Offringa M，De Jaegere AP，et al．Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopulmonary dysplasia：a systematic review of placebo-controlled trials[J]．Pediatrics，2009，123(1):367-377．
|
| [17] |
Bancalari E，Wilson-Costello D，Iben SC．Management of infants with bronchopulmonary dysplasia in North America[J]．Early Hum Dev，2005，81(2):171-179．
|
| [18] |
Miller JD，Carlo WA．Safety and effectiveness of permissive hypercapnia in the preterm infant[J]．Curr Opin Pediatr，2007，19(2) :142-144．
|
| [19] |
Subramanian S，El-Mohandes A，Dhanireddy R，et al．Association of bronchopulmonary dysplasia and hypercarbia in ventilated infants with birth weights of 500-1 499 g[J]．Matern Child Health J，2011，15(Suppl 1):S17-S26．
|
| [20] |
Halliday HL，Ehrenkranz RA，Doyle LW．Delayed (>3 weeks)postnatal corticosteroids for chronic lung disease in preterm infants[J]．Cochrane Database Syst Rev，2003，(3)，CD001145．
|
| [21] |
Baraldi E，Filippone M．Chronic lung disease after premature birth[J]．N Engl J Med，2007，357(19):1946-1955．
|
| [22] |
Pantalitschka T，Poets CF．Inhaled drugs for the prevention and treatment of bronchopulmonary dysplasia[J]．Pediatr Pulmonol，2006，41(8):703-708．
|